Aldosterone regulates cellular turnover and mitogen-activated protein kinase family expression in the neonatal rat kidney

Journal of Cellular Physiology

Volumn 219, Issue 3, 2009, Pages 724-733

  Hyung, Eun Yim ^a   Kee, Hwan Yoo ^a,b   In, Sun Bae ^a   Gi, Young Jang ^a   Young, Sook Hong ^a   Joo, Won Lee ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CYCLINE; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 9; MITOGEN ACTIVATED PROTEIN KINASE P38; OLIVE OIL; SPIRONOLACTONE; ALDOSTERONE ANTAGONIST;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CONTACT; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY DEVELOPMENT; NEWBORN; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

RATTUS;

ALDOSTERONE; ALDOSTERONE ANTAGONISTS; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL PROLIFERATION; KIDNEY; MAP KINASE SIGNALING SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MINERALOCORTICOID; RENIN-ANGIOTENSIN SYSTEM; SPIRONOLACTONE;

EID: 64549089670     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21723     Document Type: Article

References (32)

1. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH, Yancopoulos GD. 1991. ERKs: a family of protein-serine/threonine knases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663-675.
2. Choi BM, Yoo KH, Bae IS, Oh MH, Hong YS, Lee JW, Kim SK. 2005. Angiotensin-converting enzyme inhibition modulates mitogen-activated protein kinase family expressions in the neonatal rat kidney. Pediatr Res 57:115-123. (Pubitemid 40039901)
3. Choi JH, Yoo KH, Cheon HW, Kim KB, Hong YS, Lee JW, Kim SK, Kim CH. 2002. Angiotensin converting enzyme inhibition decreases cell turnover in the neonatal rat heart. Pediatr Res 52:325-332. (Pubitemid 34920260)
4. Coles HS, Burene JF, Raff MC. 1993. Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118:777-784. (Pubitemid 23232785)
5. Galabova-Kovacs G, Kolbus A, Matzen D, Galabova-Kovacs G, Kolbus A, Matzen D, Meissl K, Piazzolla D, Rubiolo C, Steinitz K, Baccarini M. 2006. ERK and beyond: insights from B-Raf and Raf-1 conditional knockouts. Cell Cycle 5:1514-1518. (Pubitemid 44091970)
6. Gallazzini M, Karim Z, Bichara M. 2006. Regulation of ROMK (Kir 1.1) channel expression in kidney thick ascending limb by hypertonicity: role of TonEBP and MAPK pathways. Nephron Physiol 104:126-135. (Pubitemid 44875779)
7. Gallego M, Espina L, Vegas L, Echevarria E, Iriarte MM, Casis O. 2001. Spironolactone and captopril attenuates isoproterenol-induced cardiac remodeling in rats. Pharmacol Res 44:311-316. (Pubitemid 32977923)
8. Gekle M, Freudinger R, Mildenberger S, Schenk K, Marschitz I, Schramek H. 2001. Rapid activation of Na+/H+-exchange in MDCK cells by aldosterone involves MAP-kinase ERK1/2. Pflugers Arch 441:781-786. (Pubitemid 32186544)
9. Giroux S, Tremblay M, Bernard D, Cardin-Girard JF, Aubry S, Larouche L, Rousseau S, Huot J, Landry J, Jeannotte L, Charron J. 1999. Embryonic death of Mek-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta. Curr Biol 9:369-372. (Pubitemid 29194878)
10. Greene EL, Kren S, Hostetter TH. 1996. Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 98:1063-1068. (Pubitemid 26293326)
11. Hendron E, Stockand JD. 2002. Activation of mitogen-activated protein kinase (mitogen-activated protein kinase/extracellular signal-regulated kinase) cascade by aldosterone. Mol Biol Cell 13:3042-3054. (Pubitemid 35034244)
12. Hida M, Omori S, Awazu M. 2002. ERK and p38 MAP kinase are required for rat renal development. Kidney Int 61:1252-1262. (Pubitemid 34304485)
13. Ishizawa K, Izawa Y, Ito H, Miki C, Miyata K, Fujita Y, Kanematsu Y, Tsuchiya K, Tamaki T, Nishiyama A, Yoshizumi M. 2005. Aldosterone stimulates vascular smooth muscle cell proliferation via big mitogen-activated protein kinase 1 activation. Hypertension 46:1046-1052.
14. Kang NS, Yim HE, Bae IS, Choi JH, Choi BM, Yoo KH, Hong YS, Lee JW, Kim SK. 2003. ACE inhibition modulates transforming growth factor-[beta] receptors in the young rat. Pediatr Nephrol 18:865-871. (Pubitemid 37121617)
15. Kuan CY, Yang DD, Samanta Roy DR, Davis RJ, Rakic P, Flavell RA. 1999. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22:667-676. (Pubitemid 29203491)
16. Lewis TS, Shapiro PS, Ahn NG. 1998. Signal transduction through MAP kinase cascades. Adv Cancer Res 74:49-139. (Pubitemid 28193546)
17. Manegold JC, Falkenstein E, Wehling M, Christ M. 1999. Rapid aldosterone effects on tyrosine phosphorylation in vascular smooth muscle cells. Cell Mol Biol 45:805-813. (Pubitemid 30028801)
18. Mikula M, Schreiber M, Husak, Kucerova L, Rüth J, Wieser R, Zatloukal K, Beug H, Wagner EF, Baccarini M. 2001. Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J 20:1952-1962. (Pubitemid 32397397)
19. Nagai Y, Miyata K, Sun GP, Rahman M, Kimura S, Miyatake A, Kiyomoto H, Kohno M, Abe Y, Yoshizumi M, Nishiyama A. 2005. Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts. Hypertension 46:1039-1045.
20. Nigam SK, Aperia AC, Brenner BM. 1996. Development and maturation of the kidney. In: Brenner BM, Rector FC, editors. The Kidney. Philadelphia: WB Saunders Company. pp. 72-98.
21. Omori S, Hida M, Ishikura K, Kuramochi S, Awazu M. 2000. Expression of mitogen-activated protein kinase family in rat renal development. Kidney Int 58:27-37. (Pubitemid 30429846)
22. Pages G, Guerin S, Grall D, Bonino F, Smith A, Anjuere F, Auberger P, Pouysségur J. 1999. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286:1374-1377. (Pubitemid 129516242)
23. Pramanik R, Qi X, Borowicz S, Choubey D, Schultz RM, Han J, Chen G. 2003. p38 isoforms have opposite effects on AP-1-dependent transcription through regulation of c-Jun. The determinant roles of the isoforms in the p38 MAPK signal specificity. J Biol Chem 278:4831-4839. (Pubitemid 36800988)
24. Sorenson CM, Sheibani N. 2002. Sustained activation of MAPK/ERKs signaling pathway in cystic kidneys from bcl-2 -/- mice. Am J Physiol Renal Physiol 283:1085-1090. (Pubitemid 35192475)
25. Taruno A, Niisato N, Marunaka Y. 2007. Hypotonicity stimulates renal epithelial sodium transport by activating JNK via receptor tyrosine kinases. Am J Physiol Renal Physiol 293:128-138. (Pubitemid 47345011)
26. Terada Y, Kobayashi T, Kuwana H, Tanaka H, Inoshita S, Kuwahara M, Sasaki S. 2005. Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1/2, cyclin D1, and cyclin A. J Am Soc Nephrol 16:2296-2305.
27. Tian W, Zhang Z, Cohen DM. 2000. MAPK signaling and the kidney. Am J Physiol Renal Physiol 279:593-604.
28. Umbhauer M, Marshall CJ, Mason CS, Old RW, Smith JC. 1995. Mesoderm induction in Xenopus caused by activation of MAP kinase. Nature 376:58-62.
29. Umenishi F, Schrier RW. 2003. Hypertonicity-induced aquaporin-1 (AQP1) expression is mediated by the activation of MAPK pathways and hypertonicity-responsive element in the AQP1 gene. J Biol Chem 278:15765-15770. (Pubitemid 36799689)
30. Woolf AS, Welham SJ. 2002. Cell turnover in normal and abnormal kidney development. Nephrol Dial Transplant 17:S2-S4.
31. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
32. Yim HE, Kim MK, Bae IS, Kim JH, Choi BM, Yoo KH, Hong YS, Lee JW. 2006. AT1 antagonist modulates activin-like kinase 5 and TGF-beta receptor II in the developing kidney. Pediatr Nephrol 21:1377-1388. (Pubitemid 44283468)